Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 USD | -0.77% | -0.77% | -5.15% |
Mar. 14 | AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 30 | Transcript : AVROBIO, Inc., Tectonic Therapeutic, Inc. - M&A Call |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 57.87M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -46M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.97
x | P/E ratio 2025 * |
-2.93
x | Employees | 78 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 2.62% |
Latest transcript on AVROBIO, Inc.
1 day | -0.77% | ||
1 week | -0.77% | ||
Current month | -1.53% | ||
3 months | -0.77% | ||
6 months | -16.77% | ||
Current year | -5.15% |
Managers | Title | Age | Since |
---|---|---|---|
Erik Ostrowski
CEO | Chief Executive Officer | 51 | 19-01-01 |
Richard Pfeifer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Azadeh Golipour
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Philip Donenberg
BRD | Director/Board Member | 63 | 18-06-19 |
Ian Clark
BRD | Director/Board Member | 62 | 17-12-31 |
Bruce Booth
CHM | Chairman | 49 | 16-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 1.29 | -0.77% | 301,725 |
24-03-15 | 1.3 | +2.36% | 493,543 |
24-03-14 | 1.27 | -1.55% | 177,195 |
24-03-13 | 1.29 | +0.78% | 176,659 |
24-03-12 | 1.28 | -1.54% | 112,495 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.15% | 57.87M | |
+1.10% | 106B | |
+9.29% | 103B | |
-3.93% | 21.44B | |
-11.89% | 22.11B | |
-26.59% | 20.99B | |
-5.20% | 19.44B | |
-6.58% | 17.6B | |
+5.83% | 13.88B | |
+7.46% | 11.75B |